Neurent Medical inks $25m Series B
Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing.
Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
